Difference between revisions of "HAEM4:B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities"
Jump to navigation
Jump to search
Bailey.Glen (talk | contribs) (Created page with "{{Under Construction}} ==Primary Author(s)*== Put your text here __TOC__ ==Graphical Data Links== Put your graphics here ==General Disease Overview / Description of Canc...") |
Bailey.Glen (talk | contribs) |
||
| Line 17: | Line 17: | ||
==WHO Classification Pages (Includes Links to Content)== | ==WHO Classification Pages (Includes Links to Content)== | ||
| − | *[[B- | + | *[[HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion]] |
| − | *[[B | + | *[[HAEM5:B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement]] |
| − | *[[B | + | *[[HAEM5:B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion]] |
| − | *[[B- | + | *[[HAEM5:B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy]] |
| − | *[[B- | + | *[[HAEM5:B-lymphoblastic leukaemia/lymphoma with hypodiploidy]] |
| − | *[[B | + | *[[HAEM5:B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion]] |
| − | *[[B | + | *[[HAEM5:B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion]] |
| − | *[[B- | + | *[[HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features]] |
| − | *[[B- | + | *[[HAEM5:B-lymphoblastic leukaemia/lymphoma with iAMP21]] |
| − | *[[B- | + | *[[HAEM5:B-lymphoblastic leukaemia/lymphoma]] |
==Other Related Pages (Includes Links to Content)== | ==Other Related Pages (Includes Links to Content)== | ||
| − | *[[B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4]] | + | *[[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4]] |
| − | *[[B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6]] | + | *[[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6]] |
| − | *[[B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)]] | + | *[[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)]] |
| − | *[[B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions]] | + | *[[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions]] |
| − | *[[B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)]] | + | *[[HAEM4:B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)]] |
==Additional Information== | ==Additional Information== | ||
Latest revision as of 16:30, 4 December 2023
 | This page is under construction |
Primary Author(s)*
Put your text here
Graphical Data Links
Put your graphics here
General Disease Overview / Description of Cancer Category
Put your text here
WHO Classification Pages (Includes Links to Content)
- HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1 fusion
- HAEM5:B lymphoblastic leukaemia/lymphoma with KMT2A rearrangement
- HAEM5:B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion
- HAEM5:B-lymphoblastic leukaemia/lymphoma with high hyperdiploidy
- HAEM5:B-lymphoblastic leukaemia/lymphoma with hypodiploidy
- HAEM5:B lymphoblastic leukaemia/lymphoma with IGH::IL3 fusion
- HAEM5:B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion
- HAEM5:B-lymphoblastic leukaemia/lymphoma with BCR::ABL1-like features
- HAEM5:B-lymphoblastic leukaemia/lymphoma with iAMP21
- HAEM5:B-lymphoblastic leukaemia/lymphoma
Other Related Pages (Includes Links to Content)
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
- HAEM4:B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
Additional Information
Put your text here
References
(use "Cite" icon at top of page)
EXAMPLE Book
- Arber DA, et al., (2008). Acute myeloid leukaemia with recurrent genetic abnormalities, in World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edition. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, Editors. IARC Press: Lyon, France, p117-118.
Notes
*Primary authors will typically be those that initially create and complete the content of a page. If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage). Additional global feedback or concerns are also welcome.
*The hierarchical tumour classification structure displayed on this page is reproduced from the WHO Classification of Tumours with permission from the copyright holder, ©International Agency for Research on Cancer.